Discovery of CPI-1612: A Potent, Selective, and Orally Bioavailable EP300/CBP Histone Acetyltransferase Inhibitor
CPI-1612 的发现:一种高效、选择性强且口服生物利用度高的 EP300/CBP 组蛋白乙酰转移酶抑制剂
期刊:ACS Medicinal Chemistry Letters
影响因子:4
doi:10.1021/acsmedchemlett.0c00155
Wilson, Jonathan E; Patel, Gaurav; Patel, Chirag; Brucelle, Francois; Huhn, Annissa; Gardberg, Anna S; Poy, Florence; Cantone, Nico; Bommi-Reddy, Archana; Sims, Robert J 3rd; Cummings, Richard T; Levell, Julian R